Business · 09/03/2001

FDA Releases Guidance on Expedited Review Process for New Animal Drugs Reducing Human Pathogens

The Food and Drug Administration (FDA) has made available a guidance document (#121) outlining the process for granting expedited review status for new animal drug applications aimed at reducing human pathogens in food-producing animals